| 产品名称 | CAS 登录号 | 分子式 |
|---|---|---|
| 替诺福韦单水合物 | 206184-49-8 | C9H14N5O4P.H2O |
| (S)-替诺福韦二吡呋酯 | 1280130-08-6 | C19H30N5O10P |
| 替诺福韦二磷酸酯 | 166403-66-3 | C9H16N5O10P3 |
| 替诺福韦相关化合物15 | 1796539-83-7 | C10H16N5O4P |
| 替诺福韦相关化合物4 | 851456-00-3 | C15H25N6O5P |
| 替诺福韦相关化合物8 | 1883563-86-7 | C22H40N7O6P |
| 替诺福韦酯 | 201341-05-1 | C19H30N5O10P |
| 替诺立定 | 24237-54-5 | C17H20N2O2S |
| 替诺昔康 | 59804-37-4 | C13H11N3O4S2 |
| 替诺昔康环合物 | 98827-44-2 | C8H7NO5S2 |
| 替培啶 | 5169-78-8 | C15H17NS2 |
| Tiplaxtinin | 393105-53-8 | C24H16F3NO4 |
| 替普瑞酮 | 6809-52-5 | C23H38O |
| Tirabrutinib | 1351636-18-4 | C25H22N6O3 |
| Tirasemtiv | 1005491-05-3 | C12H14N4O |
| 替瑞酰胺 | 55837-29-1 | C28H41N3O3 |
| 锑酸钠 | 15432-85-6 | NaSbO3 |
| 替索骨化酯 | 156965-06-9 | C31H48O5 |
| Tivantinib | 905854-02-6 | C23H19N3O2 |
| 梯希爱 | 420-12-2 | C2H4S |
| 替硝林 | 1595275-62-9 | C75H101N9O23 |
| 替硝唑 | 19387-91-8 | C8H13N3O4S |
| Tixosorb | 1340-69-8 | |
| 替泽特吉 | 2097416-76-5 | C24H24F2N8O2 |
| 替扎尼定 | 51322-75-9 | C9H8ClN5S |
| 替扎尼定-d4 盐酸盐 | 1188263-51-5 | C9H4ClD4N5S.HCl |
| 替占帕奈 | 154652-83-2 | C13H21N5O2 |
| 替哲帕肽 | 2023788-19-2 | C225H348N48O68 |
| 替唑尼特 | 173903-47-4 | C10H7N3O4S |
| Tlr2-IN-C29 | 363600-92-4 | C16H15NO4 |
| Tmb-PS | 102062-36-2 | C19H25N2NaO3S |
| TMC 353121 | 857066-90-1 | C32H42N6O3 |
| TMC 435350 | 923604-59-5 | C38H47N5O7S2 |
| TMC 647055 | 1204416-97-6 | C32H38N4O6S |
| Toceranib | 356068-94-5 | C22H25FN4O2 |
| Toddanol | 77715-99-2 | C16H18O5 |
| Toddanone | 77636-08-9 | C16H18O5 |
| Tomentin | 28449-62-9 | C11H10O5 |
| Tonabersat | 175013-84-0 | C20H19ClFNO4 |
| 铜 | 7440-50-8 | Cu |
| GHK 铜 | 89030-95-5 | C14H22CuN6O4 |
| 铜(1+)三氟甲烷硫醇-2,2'-联吡啶(1:1:1) | 1413732-47-4 | C11H8CuF3N2S |
| 通150138 | 273388-09-3 | C22H18Cl2FN3O3S |
| 3-酮-4-氮杂-5a-雄烷-17b-羧酸 | 103335-55-3 | C19H29NO3 |
| EDTA-铜铵络合物 | 67989-88-2 | C10H20CuN4O8 |
| 6-酮雌二醇 | 571-92-6 | C18H22O3 |
| 2-酮丁酸 | 600-18-0 | C4H6O3 |
| 3-酮庚酸甲酯 | 39815-78-6 | C8H14O3 |
| 通光藤甙元乙 | 80508-42-5 | C21H32O5 |
| 通关藤苷 F | 928151-78-4 | C35H56O12 |